Fundraising Fox

Venture-Backed Startups

131,038 companies with verified investor relationships.

Cypress Performance Group

0 investors

Cypress Tree

0 investors

Cypress Tree Investment Group

0 investors

Cypressfivestar

Cypress Five Star Inc operates fast casual restaurant franchises, including Blaze Pizza and Five Guys locations across Canada and the United States. The company has run these food service outlets since 2010.

1 investor

Cypris

Cypris provides AI-powered patent intelligence and IP research tools for R&D and intellectual property teams, enabling them to analyze patent landscapes, assess freedom-to-operate risks, and conduct competitive intelligence across over 180 million patents globally combined with scientific literature and market data.

3 investors

Cypris Medical

Cypris Medical develops minimally-invasive medical devices and treatments designed specifically for plastic surgeons to deliver results comparable to traditional surgery with shorter recovery times. The company combines medical device expertise with input from practicing surgeons to address unmet needs in the plastic surgery market.

0 investors

Cyprium Therapeutics

Cyprium Therapeutics develops therapies for rare genetic diseases, with a focus on treatments for Menkes disease. The company's pipeline includes ZYCUBO (copper histidinate) and AAV-ATP7A gene therapy candidates.

0 investors

Cyprus

MetLife Cyprus is the local operation of insurance provider MetLife, offering insurance products and customer service to clients in Cyprus.

1 investor

Cyracom International

0 investors

Cyral

Cyral provides agentless database security monitoring across cloud, on-premises, and SaaS environments. The platform detects and blocks suspicious database access, discovers sensitive data, and automatically remediates security misconfigurations.

1 investor

Cyramedx Holdings

0 investors

Cyrano Therapeutics

Develops regenerative therapy for persistent smell loss, currently in Phase 2 clinical trials.

1 investor

Cyrano Therateutics

Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.

1 investor

Cyranobrands

Cyrano is a brand-building platform that handles behind-the-scenes operations—investing, building, launching, operating, and scaling—for creators and brand founders. It positions itself as an operational engine for modern consumer brands.

1 investor

Cyranosystems

Cyrano Video provides subscription-based video production services combining customized hardware, software, and editorial support for healthcare organizations. The platform enables clients to produce video content at scale across multiple formats—in-studio, at-desk, and mobile—for enhanced internal communication, patient engagement, and personalized outreach.

1 investor

Cyrcadia

Cyrcadia Health develops technology based on circadian rhythm science to detect tissue disruption and cancer risk. The company's core innovation relates circadian clock dysregulation to cancer development and prognosis.

0 investors

Cyrebro

Cyrebro Neurosignals develops a neurotechnology platform using EEG and AI to analyze brain activity in real time, providing digital neuromarkers for healthcare applications and consumer product development. The platform serves healthcare professionals, clinical researchers, and consumer product companies in mental health, neurological treatment, and product optimization.

1 investor

Cyrebro

CYREBRO provides digital forensic investigation and security operations center (SOC) services for enterprises, including threat detection, incident response, and threat hunting to minimize the impact of cyberattacks.

3 investors

CyrenCare

CyrenCare provides digital patient intake software that captures clinical information through customizable forms and generates clinician-friendly reports for healthcare providers. The platform supports multilingual service delivery.

1 investor

CYRISMA

Cyrisma provides a unified cybersecurity platform combining attack surface, vulnerability, data, and compliance management, including asset discovery and patching, in a single multi-tenant tool. It is built specifically for MSPs and MSSPs to manage and scale their security services for client environments.

1 investor

CYRKL

Cyrkl operates a digital marketplace for waste and residual materials in Europe and provides waste management consulting, including waste stream analysis (Circular Waste Scans) to identify CO2 and cost savings. It serves companies looking to turn waste into resources, along with market analyses and recycling technology transfer.

1 investor

Cyrus

Cyrus provides a mobile app for personal cybersecurity and financial protection, offering account monitoring, dark web scanning, credit monitoring across three bureaus, VPN services, and fraud support for consumers.

2 investors

Cyrus 2.0

0 investors

Cyrusbio

Cyrus operates a protein engineering platform that combines AI and Rosetta computational design methods with a biochemistry lab performing large-scale deep mutagenesis scanning, protein stabilization, immunogenicity reduction, and affinity/specificity tuning. It designs and re-engineers biologic therapeutics, working on internal and partnered drug programs including COVID assets and gene therapy candidates.

8 investors